Cardiometabolic Disease Consulting Services
Obesity Treatment
Expertise in GLP-1 receptor agonism and peptide GPCRs to develop effective treatments for obesity, leveraging cutting-edge science to achieve better patient outcomes.
Multi-agonism and Combination Therapies
Develop and optimize multi-agonist approaches and combination therapies to enhance treatment efficacy and tackle obesity from multiple biological pathways.
Future Strategies in Obesity Treatment
Identify and explore new therapeutic targets and innovative strategies, combining current treatments with emerging approaches to create more effective obesity interventions.
Type 2 Diabetes
Leverage extensive knowledge and experience from working with insulin and GLP-1.
MASH (Metabolic Associated Steatohepatitis)
Implement strategies with a positive impact on liver tissue, focusing on reducing inflammation and fibrosis associated with MASH, to improve overall liver health and function.
Chronic Kidney Disease (CKD)
Provide insights and strategies for managing CKD, focusing on slowing disease progression and improving patient quality of life through targeted pharmacological interventions.
Stem Cell Therapy
Offer specialized guidance on therapeutic strategies aimed at cell therapy success.
Cardiovascular Disease
Insight into protection from cardiovascular disease afforded by new pharmacologies.
